nad has been researched along with dinoprostone in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (36.36) | 18.7374 |
| 1990's | 7 (21.21) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 9 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Manabe, T; Tobe, T | 1 |
| Arai, T; Mak, OT; Tai, CL; Tai, HH | 1 |
| Tai, HH; Tian, ZG; Xun, CQ | 1 |
| Ensor, CM; Tai, HH; Xun, CQ | 1 |
| Ratnam, SS; Roy, AC; Sen, DK | 1 |
| DeCandido, S; Satriano, JA; Schlondorff, D | 1 |
| Jarabak, J; Lindheimer, M; Watkins, JD | 1 |
| Carroll, MA; Ferreri, NR; McGiff, JC; Miller, MJ; Schwartzman, M | 1 |
| Albanase, CT; Chao, PH; Marion, DN; Pieroni, JP; Sarubbi, D; Vaughan, ED; Wong, PY | 1 |
| Abel, MH; Kelly, RW | 1 |
| Pennington, SN; Taylor, WA | 1 |
| Camp, R; Fincham, N | 1 |
| Kudriavtseva, GV; Makarov, SA; Sekretareva, EV | 1 |
| Ekblad, U; Erkkola, R; Uotila, P | 1 |
| Tai, HH | 1 |
| de Vernejoul, MC; Delage-Mourroux, R; Frendo, JL; Jullienne, A; Maclouf, J; Moukhtar, MS; Pichaud, F; Roux, S | 1 |
| Tai, HH; Zhou, H | 1 |
| Caruso, A; Challis, JR; Pomini, F | 1 |
| Cho, H; Tai, HH | 1 |
| David Percival, M | 1 |
| Cho, H; Hamza, A; Tai, HH; Zhan, CG | 1 |
| Daikoku, T; Dannenberg, AJ; Dey, SK; Du, B; Greifer, M; Otani, T; Petrovic, L; Scherl, E; Subbaramaiah, K; Tai, HH; Yamaguchi, K | 1 |
| de Paulet, AC; Descomps, B; Saintot, M; Thaler-Dao, H | 1 |
| Cho, H; Gao, D; Hamza, A; Huang, L; Tai, HH; Zhan, CG | 1 |
| Benvenuto, F; Bruzzone, S; De Flora, A; Ferraris, C; Fruscione, F; Guida, L; Ilengo, C; Jacchetti, E; Quarto, R; Salis, A; Scaglione, S; Scarfì, S; Uccelli, A; Usai, C; Zocchi, E | 1 |
| Bhatia, C; Guo, K; Heightman, TD; Jadhav, A; Maloney, DJ; Niesen, FH; Oppermann, U; Pilka, ES; Schultz, L; Simeonov, A; Wang, M | 1 |
| Giaume, C; Orellana, JA; Sáez, JC; von Bernhardi, R | 1 |
| Bol, M; Bukauskas, FF; Bultynck, G; De Bock, M; Decrock, E; Gadicherla, A; Leybaert, L; Rogiers, V; Vinken, M; Wang, N | 1 |
| Berg, AH; Bhasin, MK; Clish, CB; Karumanchi, SA; Khankin, EV; Kim, W; Parikh, SM; Rhee, EP; Stillman, IE; Tran, MT; Zsengeller, ZK | 1 |
| Cho, H; Choi, CH; Karna, S; Moon, YS; Sun, KH | 1 |
| Cai, X; Chen, S; Cong, R; Fu, P; Lou, L; Mao, L; Tao, K; Zhu, Y | 1 |
| Deng, H; Hu, Y; Wang, Q; Wang, W; Wang, X | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 review(s) available for nad and dinoprostone
| Article | Year |
|---|---|
Glial hemichannels and their involvement in aging and neurodegenerative diseases.
Topics: Adenosine Triphosphate; Aging; Astrocytes; Calcium; Cannabinoids; Central Nervous System; Connexin 43; Connexins; Dinoprostone; Glucose; Glutamic Acid; Humans; Inflammation; Interleukin-1beta; Ion Channels; NAD; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Oligodendroglia; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
Paracrine signaling through plasma membrane hemichannels.
Topics: Adenosine Triphosphate; Animals; Cell Membrane; Connexin 26; Connexins; Dinoprostone; Glutamic Acid; Glutathione; Humans; Membrane Potentials; NAD; Paracrine Communication; Protein Processing, Post-Translational | 2013 |
31 other study(ies) available for nad and dinoprostone
| Article | Year |
|---|---|
Impaired hepatic energy metabolism in rat acute pancreatitis: protective effects of prostaglandin E2 and synthetic protease inhibitor ONO 3307.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acute Disease; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cathepsin B; Dinoprostone; Energy Metabolism; Guanidines; Hydroxybutyrates; Liver; Liver Diseases; Lysosomes; Malate Dehydrogenase; Male; Mitochondria, Liver; NAD; Pancreatitis; Protease Inhibitors; Rats; Rats, Inbred Strains | 1992 |
Monoclonal antibodies that inhibit the enzyme activity of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Topics: Animals; Antibodies, Monoclonal; Binding Sites; Binding Sites, Antibody; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Epitopes; Female; Humans; Hybridomas; Hydroxyprostaglandin Dehydrogenases; Immunoblotting; Mice; Mice, Inbred BALB C; NAD; Placenta; Pregnancy | 1990 |
Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Blotting, Western; Dimethyl Sulfoxide; Dinoprostone; Enzyme Activation; Enzyme Induction; Humans; Hydroxyprostaglandin Dehydrogenases; Isoquinolines; Kinetics; Leukemia, Promyelocytic, Acute; NAD; Piperazines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1991 |
Regulation of synthesis and activity of NAD(+)-dependent 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells.
Topics: Blotting, Western; Carcinogens; Cell Line; Dexamethasone; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Humans; Hydroxyprostaglandin Dehydrogenases; Kinetics; Leukemia, Erythroblastic, Acute; Methionine; NAD; Phorbol Esters; Steroids; Sulfur Radioisotopes; Tetradecanoylphorbol Acetate | 1991 |
Evidence for several fold more activity of NAD+-dependent uterine prostaglandin 15-hydroxydehydrogenase in transsexual than in non-transsexual women.
Topics: Adult; Dinoprost; Dinoprostone; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Kinetics; NAD; Pregnancy; Transsexualism; Uterus | 1989 |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells.
Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Proteins; In Vitro Techniques; Kidney Glomerulus; Membrane Proteins; Molecular Weight; NAD; Pertussis Toxin; Platelet Activating Factor; Prostaglandins E; Rats; Virulence Factors, Bordetella | 1986 |
In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies.
Topics: Adolescent; Adult; Dinoprostone; Eclampsia; Epoprostenol; Female; Humans; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; NAD; NADP; Placenta; Pre-Eclampsia; Pregnancy; Prostaglandins E | 1987 |
Enriched prostaglandin E-9 ketoreductase activity in outer medullary cells of the rabbit kidney.
Topics: Animals; Dinoprost; Dinoprostone; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; Kidney Cortex; Kidney Medulla; Male; NAD; Prostaglandins E; Prostaglandins F; Rabbits | 1985 |
Deficiency in 15-hydroxyprostaglandin dehydrogenase activity after unilateral ureteral obstruction of the dog kidney.
Topics: Animals; Dinoprost; Dinoprostone; Dogs; Epoprostenol; Hydroxyprostaglandin Dehydrogenases; Kidney; NAD; Prostaglandins E; Prostaglandins F; Renal Circulation; Stereoisomerism; Substrate Specificity; Ureteral Obstruction | 1985 |
Metabolism of prostaglandins by the nonpregnant human uterus.
Topics: 15-Oxoprostaglandin 13-Reductase; Adult; Dinoprost; Dinoprostone; Endometrium; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Kinetics; Menstruation; Middle Aged; Myometrium; NAD; NADP; Oxidoreductases; Prostaglandins E; Prostaglandins F; Uterus | 1983 |
Kinetic changes in rat renal 15-hydroxy-prostaglandin dehydrogenase induced by chronic ethanol exposure.
Topics: Animals; Dinoprostone; Ethanol; Hydroxyprostaglandin Dehydrogenases; Kidney; Kinetics; Male; NAD; NADP; Prostaglandins E; Rats; Substrate Specificity | 1983 |
Novel prostaglandin dehydrogenase in rat skin.
Topics: Animals; Dinoprost; Dinoprostone; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; Kinetics; NAD; NADP; Prostaglandins E; Prostaglandins F; Rats; Skin; Subcellular Fractions | 1983 |
[Effect of series E and F prostaglandins on the reaction of the pentosephosphate pathway of carbohydrate metabolism in isolated perfused rat organs].
Topics: Animals; Cytosol; Dinoprost; Dinoprostone; Female; Glucosephosphate Dehydrogenase; In Vitro Techniques; Liver; NAD; NADP; Oxidation-Reduction; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Prostaglandins E; Prostaglandins F; Rats; Transketolase; Uterus | 1984 |
Prostaglandin E2 is only slightly metabolized in the fetal circulation of perfused human placenta.
Topics: Arteries; Chorion; Dinoprostone; Female; Humans; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; Kinetics; NAD; Perfusion; Placenta; Pregnancy; Prostaglandins E; Veins | 1982 |
Assay of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase using (15S)-[15-3H]PGE2.
Topics: Dinoprostone; Hydroxyprostaglandin Dehydrogenases; Isotope Labeling; NAD; Prostaglandins E; Tritium | 1982 |
1,25-dihydroxyvitamin D3 induces NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes.
Topics: Adult; Calcitriol; Culture Media; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Enzyme Induction; Fetal Blood; Humans; Hydroxyprostaglandin Dehydrogenases; Isoenzymes; Membrane Proteins; Monocytes; NAD; Polymerase Chain Reaction; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 1997 |
Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Binding Sites; Blotting, Western; Catalysis; Conserved Sequence; Dinoprostone; Escherichia coli; Humans; Hydroxyprostaglandin Dehydrogenases; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; NAD; Placenta; Protons; Recombinant Proteins; Sequence Alignment; Threonine | 1999 |
Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast a
Topics: Cells, Cultured; Chorion; Chorionic Villi; Dinoprost; Dinoprostone; Female; Gene Expression; Humans; Hydroxyprostaglandin Dehydrogenases; Interleukin-1; Interleukin-10; Kinetics; NAD; Pregnancy; Prostaglandin-Endoperoxide Synthases; Prostaglandins; RNA, Messenger; Trophoblasts; Tumor Necrosis Factor-alpha | 1999 |
Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Inhibitory Concentration 50; Isoenzymes; Kinetics; Membrane Proteins; NAD; Placenta; Prostaglandin-Endoperoxide Synthases; Thiazoles; Thiazolidinediones | 2002 |
Continuous spectrophotometric assay amenable to 96-well plate format for prostaglandin E synthase activity.
Topics: Dinoprostone; Hydroxyprostaglandin Dehydrogenases; Intramolecular Oxidoreductases; Kinetics; NAD; Prostaglandin H2; Prostaglandin-E Synthases; Prostaglandins H; Recombinant Fusion Proteins; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry | 2003 |
Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation.
Topics: Amino Acid Sequence; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Molecular Sequence Data; NAD; Sequence Homology, Amino Acid | 2005 |
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Topics: Colon; Crohn Disease; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Enzymologic; HT29 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; In Situ Hybridization; Inflammatory Bowel Diseases; Intestinal Mucosa; NAD; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Necrosis Factor-alpha | 2006 |
Stereospecificity of hydrogen transfer by the human placental 15-hydroxy prostaglandin dehydrogenase.
Topics: Dinoprostone; Female; Humans; Hydroxyprostaglandin Dehydrogenases; NAD; Oxidation-Reduction; Placenta; Tritium | 1976 |
Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
Topics: Amino Acid Sequence; Catalysis; Crystallography, X-Ray; Dinoprostone; Escherichia coli; Glutamine; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; NAD; Oxidation-Reduction | 2006 |
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling.
Topics: Adenosine Triphosphate; Adipogenesis; Autocrine Communication; Calcium; Calcium Channels, L-Type; Cells, Cultured; Connexin 43; Cyclic AMP; Cytokines; Dinoprostone; Flow Cytometry; Gap Junctions; Humans; Mesenchymal Stem Cells; NAD; Osteogenesis; Receptors, Purinergic P2; RNA, Small Interfering; Second Messenger Systems | 2011 |
High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.
Topics: Binding Sites; Binding, Competitive; Biocatalysis; Crystallography, X-Ray; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Kinetics; Models, Molecular; Molecular Structure; NAD; Oxidation-Reduction; Protein Binding; Protein Multimerization; Protein Structure, Tertiary; Structure-Activity Relationship; Substrate Specificity | 2010 |
PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.
Topics: 3-Hydroxybutyric Acid; Acute Kidney Injury; Adipose Tissue; Amino Acids; Animals; Cytokines; Dinoprostone; Humans; Ischemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction; Stress, Physiological; Transcription Factors | 2016 |
The wound-healing effect of 7,3',4'-trimethoxyflavone through increased levels of prostaglandin E
Topics: A549 Cells; Cell Line; Dinoprostone; Dose-Response Relationship, Drug; Flavones; Gene Expression Regulation; Humans; Hydroxyprostaglandin Dehydrogenases; Multidrug Resistance-Associated Proteins; NAD; Organic Anion Transporters; Wound Healing | 2017 |
MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)].
Topics: 3' Untranslated Regions; Animals; Base Sequence; Cell Differentiation; Chondrogenesis; Dinoprostone; Female; Gene Expression Regulation; Hydroxyprostaglandin Dehydrogenases; Male; Mesenchymal Stem Cells; MicroRNAs; NAD; Osteogenesis; Rabbits; RNA, Messenger; Synovial Membrane | 2017 |
ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD
Topics: Acrylamides; ADP-ribosyl Cyclase 1; Autophagy; Cell Line, Tumor; Cell Movement; Cysteine; Dinoprostone; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Membrane Glycoproteins; Mutagenesis, Site-Directed; NAD; Niacin; Oxidation-Reduction; Piperidines; Proteasome Endopeptidase Complex; Protein Stability; Reactive Oxygen Species; Sulfonic Acids | 2018 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |